Pharma.D
via RBVRR Womens College of Pharmacy, Hyderabad
Pharm.D
via Deccan School of Pharmacy, Hyderabad
Location
Ownership
College Type
Establishment Year
Total Courses Offered
Approvals
Data presented for the year 2024
Graduating Students
(overall)
-
Total Students Placed
(overall)
-
Placement Percentage
(overall)
-
Median Salary Lpa
(overall)
-
Student Going Higher Studies
(overall)
Insight
Placement Statistics
Deccan School of Pharmacy, Hyderabad recruited highest number of students with 9 placements.
Source: NIRF
Course Credential
Degree
Branch
Duration
Mode
Approved Intake
Fees
-
Course Approval
Admission Details
Candidates who have passed the Intermediate should qualify TS EAMCET exam. Admission will be through counseling. Admissions into ‘B’ category Seats(Management quota) as per the rules of Higher Education, Govt. of Telangana. The Application Form can be downloaded from the college website.
Admissions through an entrance Exam Called TSEAMCET Every Year in the months of April-May. The students are given a Ranking based on the marks obtained in the Test and the Percentage of marks at the intermediate.
Eligibility Criteria
A candidate for admission must have passed the Intermediate.
10+2 science academic stream with Physics. Chemistry, Mathematics or Biology.
or
Diploma in Pharmacy from a PCI-approved institution.
Total Fees
Facilities
Facilities Count
Alumni Associations
Auditorium
Boys Hostel
Cafeteria
Classrooms
Girls Hostel
Gym
I.T Infrastructure
Laboratories
Library
Medical/Hospital
Parking Facility
Sports
Training and Placement Cell
Wifi
Alumni Associations
Auditorium
Cafeteria
Classrooms
Guest Room/Waiting Room
Gym
I.T Infrastructure
Laboratories
Library
Medical/Hospital
Sports
Individual Reviews
Which college/course would you like to go ahead with?
RBVRR Womens College of Pharmacy, Hyderabad
Pharma.D
Deccan School of Pharmacy, Hyderabad
Pharm.D
Popular Pharma.D Comparisons
Popular Pharm.D Comparisons
Popular Comparisons in Pharmacy
Popular Comparisons of RBVRR Womens College of Pharmacy, Hyderabad